Get the full picture
Sign in to uncover key details.
CorriXR Therapeutics
Manufacturing · Delaware, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
550 S College Ave Ste 107, Newark, Delaw...Website
www.corrixr.comRevenue
<$5 MillionIndustry
About CorriXR Therapeutics
CorriXR Therapeutics is a clinical-stage biotechnology company developing in vivo CRISPR/Cas gene editing therapies to overcome drug resistance in solid tumors. Its lead candidate, CXR101, targets the NRF2 pathway in squamous cell carcinomas, aiming to enhance treatment response and improve patient outcomes through precise, tumor-localized delivery.Explore more
CorriXR Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to CorriXR Therapeutics
Compare insights from companies similar to CorriXR Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CorriXR Therapeutics Tech Stack
A closer look at the technologies used by CorriXR Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding CorriXR Therapeutics
Sign Up For FreeTo access detailed company insights
CorriXR Therapeutics is a clinical-stage biotechnology company developing in vivo CRISPR/Cas gene editing therapies to overcome drug resistance in solid tumors. Its lead candidate, CXR101, targets the NRF2 pathway in squamous cell carcinomas, aiming to enhance treatment response and improve patient outcomes through precise, tumor-localized delivery... Read More
